Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was forme...
Manzo Pharmaceuticals reported revenue of $3.07 million for fiscal year 2004, up 2.2% from fiscal year 2003, and net income of -$4.15 million. In Q3 2005 (the quarter ended September 30, 2005) revenue was $0.
Figures from company filings; latest fiscal year ended December 31, 2004.
No profile data available.